Zomagen Biosciences

Technologiepark 94

9052 Gent

BE

Zomagen Biosciences

Foundation date

26/02/2020

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

Zomagen is a therapeutic product discovery & development biotech company focussed on compounds targeting the innate immune system, eventually to treat diseases with chronic inflammatory involvement.

Latest news

  • Antonin (Tony) de Fougerolles appointed as new Chair of etherna

    Tuesday July 16th 2024

  • ONTOFORCE Achieves ISO 27001:2022 Certification: A Milestone in Information Security and Trust

    Tuesday July 16th 2024

  • Ghent University spin-off Trince wins Nature Spinoff Prize

    Monday July 15th 2024